Figure 3

(A) PLS-DA scores plot (R2X: 0.54, R2Y:0.99, Q2 0.87). (B) OPLS-DA scores plot (R2X: 0.54, R2Y:0.99, Q2: 0.87) of CKD and ESRD groups. (C) Metabolites with the highest VIP scores in OPLS-DA model with their level in CKD and ESRD. ESRD end-stage renal disease, CKD chronic kidney disease.